Staphylococcal Infections: Clinical Trials

355 trials for Staphylococcal Infections, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

233 completed, 46 unknown, 28 terminated, 19 recruiting. 71 Not applicable, 64 Phase 2, 46 Phase 1, 45 Phase 4, 44 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable71Completed 48, Unknown 9, Recruiting 6, Terminated 3, Not yet recruiting 2, Withdrawn 2, Active not recruiting 1
Phase 264Completed 44, Terminated 7, Unknown 5, Active not recruiting 2, Not yet recruiting 2, Recruiting 2, Withdrawn 2
Phase 146Completed 30, Active not recruiting 5, Unknown 5, Not yet recruiting 2, Recruiting 2, Terminated 1, Withdrawn 1
Phase 445Completed 26, Terminated 7, Unknown 5, Recruiting 4, Withdrawn 2, Active not recruiting 1
Phase 344Completed 35, Terminated 4, Unknown 3, Recruiting 2
Early Phase 13Completed 1, Not yet recruiting 1, Withdrawn 1

Follow Staphylococcal Infections: new trials by email Literature Review of Staphylococcal Infections trials Research Report on Staphylococcal Infections

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Bacterial Decolonization to Prevent Severe Radiation Dermatitis in Head and Neck Squamous Cell Carcinoma
Bacterial decolonization, Standard Hygiene Measures - HNSCC
Not applicableNot yet recruitingInstitut Cancerologie de l'Ouest1442027-01-012026-10-22
Modeling Host-Pathogen Interaction Using Lymphoid Organoids
Staphylococcal Infections
RecruitingNational Institute of Allergy and Infectious Diseases (NIAID)5002026-11-032026-10-29
Farm-originated Antimicrobial Resistance Modeling: Exploring Humans-to-Animal Dissemination
Sample collection - Methicillin Resistance in Staphylococcus Aureus (MRSA)
Not applicableNot yet recruitingCentre Hospitalier de Saint-Brieuc202026-11-012026-10-27
Secondary Bacterial Infections and Nasal Colonization in Scabies and Atopic Dermatitis
Atopic Dermatitis (AD), Scabies
Not yet recruitingIstanbul Medeniyet University512026-10-012026-09-15
Retention of Vernix Caseosa in Newborns for Primary Prevention of Atopic Dermatitis
Retention of Vernix Caseosa After Birth, Removal of Vernix Caseosa After Birth - Atopic Dermatitis
Not applicableRecruitingPontificia Universidad Catolica de Chile13832026-09-292026-09-30
Intertriginous/Periorificial Dermatoses in Patients With IBD on Anti-TNFα: Relative Abundance of Staphylococcus Aureus Within the Lesion Microbiota and Clinical Correlation (micSPIDER).
Inflammatory Bowel Diseases, Crohn's Disease
Not yet recruitingCentre Hospitalier Universitaire de Nīmes822026-09-012026-09-10
Standard Treatment Associated With Phage Therapy Versus Placebo for Diabetic Foot Ulcers Infected by S. Aureus
Topical anti-Staphylococcus bacteriophage therapy, Topical placebo corresponding to anti-Staphylococcus bacteriophage therapy - Diabetic Foot, Staphylococcal Infections
Phase 1 / Phase 2Not yet recruitingCentre Hospitalier Universitaire de Nīmes602026-09-012026-03-20
Comparative Study of Adherence to Antibiotic Therapy Among Pediatric Patients: Hospital Emergency Department vs. Primary Care Center
Tonsillitis Acute, Pneumonia - Bacterial
Not yet recruitingUniversity Hospital, Montpellier1912026-09-012026-07-17
Thermosensitive Gel Nasal Spray With Stem Cell Exosomes, Mupirocin, and DNase I for Chronic Sinusitis
Exosomes (hUC-MSC-Exo), Mupirocin, DNase I - Chronic Rhinosinusitis With Nasal Polyps
Early Phase 1Not yet recruitingThe First Affiliated Hospital of Xinxiang Medical College1082026-07-012026-06-09
Rifampin-free Regimen Versus Rifampin-containing Regimen in the Treatment of Staphylococcal Prosthetic Valve Endocarditis
Rifampin-free regimen, Rifampin containing regimen - Infective Endocarditis
Phase 3RecruitingNantes University Hospital4222026-06-112026-10-21
Adjuvant Clopidogrel in Staphylococcus Aureus Bacteremia
Clopidogrel, No antiplatelet treatment - Bacteremia Due to Staphylococcus Aureus
Phase 2Not yet recruitingFundación Pública Andaluza para la gestión de la Investigación en Sevilla2302026-06-012026-02-05
Unbound Cloxacillin Concentrations During Continuous Infusion
Unbound cloxacillin concentration - Staphylococcal Infections
Phase 4RecruitingEmeli Månsson252026-01-142026-02-17
Light-Activated Antimicrobial Therapy to Prevent Surgical Site Infections - Canada
Nasal antimicrobial photodisinfection therapy - Surgical Site Infections, Infections
Not applicableCompletedOndine Biomedical Inc.4012026-01-132026-09-15
Comparison of Wound Healing for Diabetic Carbuncle Treated With Incision and Drainage Technique Using Cruciate Incision vs Saucerization Technique Both Followed by Vacuum Assisted Closure.
Incision & Drainage Technique Using Cruciate Incision Followed by VAC, Saucerization Technique Followed by VAC - Carbuncle
Not applicableRecruitingKing Edward Medical University1242026-01-022026-02-23
Safety of Combined Intravenous Antibiotic and Bacteriophage Therapy in Adults With Cystic Fibrosis and Antibiotic-Resistant Lung Infections
Intravenous Bacteriophage Cocktail plus Standard IV Antibiotics - CF - Cystic Fibrosis, Klebsiella Pneumoniae Infection
Phase 1Not yet recruitingUniversity of California, San Diego302025-12-312025-12-12
Linezolid Plus Standard of Care
Linezolid 600 mg, Placebo - Staphylococcus Aureus Bloodstream Infections (BSI; Bacteremia)
Not applicableRecruitingUniversity Hospital, Basel, Switzerland6062025-10-062026-07-13
Perspectives on Antibiotics and Tracking Symptoms in Children
Garmin Smartwatch - Urinary Tract Infection, Cellulitis
Not applicableRecruitingMurdoch Childrens Research Institute3002025-09-162026-10-07
Administering NMT to Reestablish Infant Nasal Microbiome Diversity Following Intranasal Mupirocin Treatment
Nasal Microbiota Transplant (NMT), Placebo - Staphylococcal Aureus Infection, Microbial Colonization
Phase 1RecruitingJohns Hopkins University1752025-08-272026-08-10
Echocardiography Versus no Echocardiography in S. Aureus Bacteraemia and VIRSTA Score < 3
systematic echocardiography, no echocardiography arm - Staphylococcus Aureus, Bacteremia
Not applicableRecruitingAssistance Publique - Hôpitaux de Paris7002025-05-142025-11-24
Decolonization Efficacy of Polyhexanide vs. Mupirocin
Polyhexanide, Mupirocin and Chlorhexidine - Staphylococcus Aureus, Colonization, Asymptomatic
Phase 4CompletedSwiss Paraplegic Research, Nottwil242025-05-012026-07-08

Showing 20 of 355. Sign in to see all of them.

Narrower conditions

Bacteremia (36)  ·  Impetigo (30)  ·  Staphylococcal Skin Infections (30)  ·  Cellulitis (25)  ·  Infections (25)  ·  Sepsis (25)  ·  Abscess (21)  ·  Surgical Wound Infection (20)  ·  Dermatitis, Atopic (15)  ·  Bacterial Infections (14)  ·  Furunculosis (14)  ·  Cross Infection (12)  ·  Pneumonia (11)  ·  Skin Diseases, Bacterial (10)

Broader conditions

Bacterial Infections and Mycoses (355)  ·  Gram-Positive Bacterial Infections (348)  ·  Bacterial Infections (341)  ·  Infections (330)  ·  Pathological Conditions, Signs and Symptoms (140)  ·  Pathologic Processes (136)  ·  Skin and Connective Tissue Diseases (106)  ·  Skin Diseases (96)  ·  Inflammation (82)  ·  Skin Diseases, Infectious (80)  ·  Skin Diseases, Bacterial (66)  ·  Systemic Inflammatory Response Syndrome (50)  ·  Staphylococcal Skin Infections (42)  ·  Disease Attributes (41)

Interventions

Vancomycin (27)  ·  Mupirocin (25)  ·  Daptomycin (20)  ·  Clindamycin (12)  ·  chlorhexidine gluconate (11)  ·  Linezolid (10)  ·  Trimethoprim, Sulfamethoxazole Drug Combination (10)  ·  Blood Specimen Collection (9)  ·  Cefazolin (7)  ·  Chlorhexidine (7)  ·  Cloxacillin (6)  ·  Rifampin (5)  ·  Ceftaroline (4)  ·  Floxacillin (4)  ·  Sodium Hypochlorite (4)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (14)  ·  Centre Hospitalier Universitaire de Saint Etienne (10)  ·  Hospices Civils de Lyon (10)  ·  Nabi Biopharmaceuticals (9)  ·  Basilea Pharmaceutica (8)  ·  Pfizer (8)  ·  Assistance Publique - Hôpitaux de Paris (7)  ·  GlaxoSmithKline (7)  ·  Merck Sharp & Dohme LLC (6)  ·  Centre Hospitalier Universitaire de Nīmes (5)  ·  Henry M. Jackson Foundation for the Advancement of Military Medicine (5)  ·  Washington University School of Medicine (5)  ·  Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) (4)  ·  Johns Hopkins University (4)  ·  University Hospital, Basel, Switzerland (4)

Countries

United States (144)  ·  France (65)  ·  Germany (24)  ·  Spain (20)  ·  United Kingdom (16)  ·  Canada (15)  ·  Israel (14)  ·  Netherlands (13)  ·  Switzerland (13)  ·  South Africa (12)  ·  Belgium (10)  ·  Mexico (9)  ·  Russia (9)  ·  Australia (8)  ·  Brazil (8)

Top investigators

Matt Hohenboken, MD, PhD (5)  ·  Lisa Beck, MD (3)  ·  Achim J Kaasch, MD (2)  ·  Albert Sotto, MD, PhD (2)  ·  Barbara C Kahl, MD (2)  ·  Daniel M Musher, MD (2)  ·  G. Ralph Corey, MD (2)  ·  Ian A Myles, M.D. (2)  ·  Ian Mr Hayter, BSc (2)  ·  Issam Raad, MD (2)  ·  Jean-Philippe Lavigne, MD PhD (2)

Results publications

PMID 18444791, PMID 19095213, PMID 20695801, PMID 21115456, PMID 22416054, PMID 27518661, PMID 29380251, PMID 30365584, PMID 30597021, PMID 30716446, PMID 31993453, PMID 34741280, PMID 34922058, PMID 35473663, PMID 39141589, PMID 41433510, PMID 12672715, PMID 14689344, PMID 16310147, PMID 16420547, PMID 16762061, PMID 16914701, PMID 16965625, PMID 17651080, PMID 17719934, PMID 17893153, PMID 18225981, PMID 19118117, PMID 19134433, PMID 19799842, PMID 19936297, PMID 20462352, PMID 20523108, PMID 20686410, PMID 20943877, PMID 21028984, PMID 21115454, PMID 21115455, PMID 21248153, PMID 21444695, PMID 21537018, PMID 21546629, PMID 21828967, PMID 22033452, PMID 22192849, PMID 22198793, PMID 22653459, PMID 22837094, PMID 23085743, PMID 23099329

NIH funding

2014 (2), 2016 (2), 2023 (2), 2018 (1), 2019 (1), 2025 (1), 5UM1AI104681-12 (1), K08AI072043 (1), R21AI179644 (1), R21AR062357 (1), S06GM142120 (1)